Testing effectiveness (Phase 2)Looking for participantsNCT07575971
What this trial is testing
Exploratory Study of CD22/CD19 Dual-Target CAR-T Cell Therapy as Consolidation Treatment After First Remission in High-Risk B-Cell Acute Lymphoblastic Leukemia
Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Liping Dou 30